ZA89723B - Renin inhibiting peptides with polar end groups - Google Patents

Renin inhibiting peptides with polar end groups

Info

Publication number
ZA89723B
ZA89723B ZA89723A ZA89723A ZA89723B ZA 89723 B ZA89723 B ZA 89723B ZA 89723 A ZA89723 A ZA 89723A ZA 89723 A ZA89723 A ZA 89723A ZA 89723 B ZA89723 B ZA 89723B
Authority
ZA
South Africa
Prior art keywords
end groups
polar end
inhibiting peptides
renin inhibiting
renin
Prior art date
Application number
ZA89723A
Other languages
English (en)
Inventor
Gordon L Bundy
L Bundy Gordon
Suvit Thaisrivongs
Thaisrivongs Suvit
Norman A Nelson
A Nelson Norman
Jackson B Hester Jr
B Hester Jackson Jr
Jed F Fisher
F Fisher Jed
Michael F Lipton
F Lipton Michael
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA89723B publication Critical patent/ZA89723B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/003Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA89723A 1988-02-01 1989-01-30 Renin inhibiting peptides with polar end groups ZA89723B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15112988A 1988-02-01 1988-02-01

Publications (1)

Publication Number Publication Date
ZA89723B true ZA89723B (en) 1989-10-25

Family

ID=22537440

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA89723A ZA89723B (en) 1988-02-01 1989-01-30 Renin inhibiting peptides with polar end groups

Country Status (9)

Country Link
EP (2) EP0329295A1 (da)
JP (1) JPH03502328A (da)
KR (1) KR900700502A (da)
AU (1) AU632468B2 (da)
DK (1) DK183090A (da)
IL (1) IL89110A0 (da)
NZ (1) NZ227786A (da)
WO (1) WO1989007109A1 (da)
ZA (1) ZA89723B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583198A (en) * 1989-12-22 1996-12-10 Commonwealth Scientific And Industrial Research Organization Amino acids, peptides or derivatives thereof coupled to fats
DK0506748T3 (da) * 1989-12-22 1996-01-22 Commw Scient Ind Res Org Aminosyrer, peptider eller derivater deraf bundet til fedtstoffer
DE4037437A1 (de) * 1990-11-24 1992-05-27 Hoechst Ag Aminodiol-derivate
US5691368A (en) * 1995-01-11 1997-11-25 Hoechst Marion Roussel, Inc. Substituted oxazolidine calpain and/or cathepsin B inhibitors
WO1998051330A1 (en) 1997-05-13 1998-11-19 Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) Method and compositions for treating hyperlipidemia and other conditions
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
AU7655098A (en) 1997-05-13 1998-12-08 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Somatostatin and somatostatin agonists for decreasing body weight
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
BR0210915A (pt) 2001-06-08 2004-06-08 Sod Conseils Rech Applic Análogos quiméricos de somatostatina-dopamina
AU2005286844A1 (en) * 2004-09-17 2006-03-30 Comentis, Inc Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof
NZ562314A (en) 2005-04-08 2010-02-26 Comentis Inc Compounds which inhibit beta-secretase activity and methods of use thereof
CA2727082C (en) 2008-06-12 2019-02-26 Syntaxin Limited Fusion proteins for use in suppression of acromegaly
CN102083451A (zh) 2008-06-12 2011-06-01 赛恩泰新公司 癌症的抑制
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
JP6869720B2 (ja) 2013-06-13 2021-05-12 アンチセンス セラピューティクス リミテッド 併用療法
CN108558685B (zh) * 2017-06-08 2020-11-20 西安力邦制药有限公司 2,6-二取代苯酚葡甲胺类衍生物及应用
EP4559896A4 (en) * 2022-07-19 2025-10-22 Univ Hokkaido Nat Univ Corp PH-SENSITIVE CATIONIC LIPID AND LIPID NANOPARTICLE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0163237A3 (en) * 1984-05-29 1988-04-27 Merck & Co. Inc. Di- and tri-peptidal renin inhibitors
DK356085A (da) * 1984-08-06 1986-02-07 Upjohn Co Reninhaemmende peptid eller et farmaceutisk acceptabelt syreadditionssalt deraf
US4729985A (en) * 1985-08-09 1988-03-08 Pfizer Inc. Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
NL194729C (nl) * 1986-10-13 2003-01-07 Novartis Ag Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
GB2200115B (en) * 1987-01-21 1990-11-14 Sandoz Ltd Novel peptide derivatives, their production and use

Also Published As

Publication number Publication date
EP0397779A1 (en) 1990-11-22
AU632468B2 (en) 1993-01-07
AU3063089A (en) 1989-08-25
WO1989007109A1 (en) 1989-08-10
EP0329295A1 (en) 1989-08-23
DK183090A (da) 1990-09-14
IL89110A0 (en) 1989-08-15
KR900700502A (ko) 1990-08-13
NZ227786A (en) 1992-02-25
DK183090D0 (da) 1990-07-31
JPH03502328A (ja) 1991-05-30

Similar Documents

Publication Publication Date Title
IL89110A0 (en) Renin inhibiting peptides with polar end groups
GB8919556D0 (en) Periscope
GB2218786B (en) Arrow gun
GB8900072D0 (en) Clamp
CS169689A2 (en) Clamp
ZA895137B (en) Novel peptides
EP0462111A4 (en) Homing sequences and their uses
GB2214953B (en) Line clamp
GB8812968D0 (en) Clamp
AU2123288A (en) Renin inhibiting peptides with nonpeptide linkages
GB2214959B (en) Marine units
ZA892269B (en) Peptides
GB8821077D0 (en) Peptides
GB8820635D0 (en) Clamp
AU3671189A (en) Renin inhibitory peptides
GB8918252D0 (en) Armour
ZA899167B (en) Peptides
GB8826741D0 (en) Cholecystogram clamp
ZA899168B (en) Peptides
GB8815302D0 (en) Decorave bow
ZA904258B (en) Renin inhibitory peptides
GB8821076D0 (en) Peptides
GB8804687D0 (en) Peptides
IE881982L (en) Peptides
IE882649L (en) Peptides